AI assistant
Ipca Laboratories Ltd. — Capital/Financing Update 2022
Sep 30, 2022
61700_rns_2022-09-30_cd47baca-7e89-461d-bf0e-a9490b9cfb7d.pdf
Capital/Financing Update
Open in viewerOpens in your device viewer
September 30, 2022
==> picture [124 x 44] intentionally omitted <==
THRU ONLINE FILING
BSE Ltd. Phiroze Jeejeebhoy Towers Dalal Street Mumbai 400 023 Scrip Code – 524494
National Stock Exchange India Limited, Exchange Plaza, C-1, Block-G, Bandra Kurla Complex, Bandra – (East), Mumbai-400051. Scrip Code : IPCALAB
Dear Sirs,
We are pleased to inform you that second plant out of the two plants set-up for manufacturing of Drug Intermedidates / Active Pharmaceuticals Ingredients (APIs) at the Company’s new green field manufacturing unit being set up at Dewas (Madhya Pradesh) with a capital outlay of about Rs. 250 crores has commenced trial production on 30[th] September, 2022.
Thanking you
Yours faithfully For Ipca Laboratories Limited
Digitally signed by Harish Pandurang Kamath Harish DN: c=IN, o=Personal, title=1715, pseudonym=3f7ac814d30fe4f87db4e251aafc bf81ab20003dc8e02a91eb3d7c33065f5b40, postalCode=400091, st=Maharashtra, Pandurang serialNumber=72050fb9fadcbc5de640468511 7b8355792f5784c7617d9c4cae2a3887d6b809 Kamath , cn=Harish Pandurang Kamath Date: 2022.09.30 17:42:24 +05'30'
Harish P. Kamath Corporate Counsel & Company Secretary ACS 6792
lpca Laboratories Ltd. www.ipca.com
125, Kandivli Industrial Estate, Kandivli (West), Mumbai 400 067 (Maharashtra), India I T:+91 22 6210 5000 F:+91 22 62105005 Regd. Office:48, Kandivli Industrial Estate, Kandivli(West), Mumbai 400 067 (Maharashtra),India I T:+91 22 6647 4444 E: [email protected] CIN: L24239MH1949PLC007837